Editas Medicine, Inc.
EDIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $104,570 | $769,532 | $609,057 | $1,795,295 |
| - Cash | $131,541 | $123,652 | $141,522 | $203,519 |
| + Debt | $35,032 | $36,536 | $43,946 | $26,378 |
| Enterprise Value | $8,061 | $682,416 | $511,481 | $1,618,154 |
| Revenue | $32,314 | $78,123 | $19,712 | $25,544 |
| % Growth | -58.6% | 296.3% | -22.8% | – |
| Gross Profit | $32,314 | $72,059 | $13,375 | $20,491 |
| % Margin | 100% | 92.2% | 67.9% | 80.2% |
| EBITDA | -$233,111 | -$163,117 | -$219,613 | -$188,093 |
| % Margin | -721.4% | -208.8% | -1,114.1% | -736.3% |
| Net Income | -$237,093 | -$153,219 | -$220,432 | -$192,502 |
| % Margin | -733.7% | -196.1% | -1,118.3% | -753.6% |
| EPS Diluted | -2.88 | -2.02 | -3.21 | -2.85 |
| % Growth | -42.6% | 37.1% | -12.6% | – |
| Operating Cash Flow | -$210,284 | -$132,178 | -$177,349 | -$163,803 |
| Capital Expenditures | -$8,826 | -$4,719 | -$4,118 | -$7,977 |
| Free Cash Flow | -$219,110 | -$136,897 | -$181,467 | -$171,780 |